Skip to main content
. 2020 May 23;2(2):80–88. doi: 10.1016/j.smhs.2020.05.005

Table 1.

Participant characteristics. Group: 1 = immediate treatment; 2 = waitlist control. Levodopa equivalent dosage was determined according to Pahwa et al., 1997.32

ID Age (years) Group Gender UPDRS-III Hoehn & Yahr Stage Disease Duration (years) Levodopa Equivalent Dosage (mg) Number of Absences in Yoga Sessions
1 72 2 M 14 2 6 450 0
2 58 2 F 16 2 2 50 2
3 67 1 F 14 1 3 150 2
4 66 2 F 23 2 3.5 750 2
5∗ 74 2 M 3 4 1000
6 57 1 F 14 3 13 1075 14
7 73 2 M 24 3 7 500 3
8 49 1 F 16 1 0.75 0 2
9 75 1 M 11 2 2.5 300 5
10 62 1 M 14 2 3 700 0
11 68 2 F 22 1 6 400 2
12 69 2 M 14 1 5.5 2386 3
13 66 1 F 13 2 4 300 0
14 62 1 F 23 3 1.5 425 2
15∗ 63 2 F 28 3 10 800 17
16 55 2 F 34 3 5.5 500 6
17 55 1 M 20 3 7 1368 3
18 76 1 M 24 3 4 450 1
19 60 2 M 23 2 1.5 300 3
20 66 1 M 26 2 2.5 0 0

Note: ∗ indicates participants who dropped the study for medical reasons unrelated to this study after recruitment.